Facing what is likely to be a mid-cycle adjustment in the U.S., equities investors can dampen the impact of earnings downgrades by focusing on quality.
Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.
Cumulative central bank policy should dampen inflation, bringing relief on rates in 2023 but the outlook for credit is set to be more challenged.
Explore the opportunity for alternatives investing following a year that tested the resilience of traditional strategies built around ‘core’ asset classes.
ESG investing faced headwinds in 2022, leading to questions about its future role. We believe ESG will remain a crucial consideration for investors.
Retailers are expected to offer plenty of discounts during the holidays. Will their stocks be a bargain, too?
The Portfolio Construction and Strategy team discusses key insights from their latest Trends and Opportunities report, entitled “Shock Therapy.”
In this episode, Myron tackles some of the toughest conundrums in risk management: when to de-risk, when to re-risk, and how to think about risk in a real, multi-period world.
As the credit cycle continues to weaken, investors should watch for an inflection point in policy, earnings, or economic growth.
A discussion on how investors can navigate the short-duration opportunity set within fixed income.
A discussion on potential investment opportunities in health care despite a record sell-off in small- and mid-cap biotech stocks.
Recent volatility has compressed semiconductor valuations, even as the industry’s long-term growth drivers gather strength.